InChI=1S/C31H48O6/c1- 17(2) 9- 8- 10- 20(28(35) 36) 26- 22- 15- 24(34) 27- 29(5) 13- 12- 23(33) 18(3) 21(29) 11- 14- 30(27,6) 31(22,7) 16- 25(26) 37- 19(4) 32/h9,18,21- 25,27,33- 34H,8,10- 16H2,1- 7H3,(H,35,36) /b26- 20- /t18- ,21- ,22- ,23+,24+,25- ,27- ,29- ,30- ,31- /m0/s1 |
IECPWNUMDGFDKC-MZJAQBGESA-N |
[H] [C@@] 12CC[C@@] 3(C) [C@@] ([H] ) ([C@H] (O) C[C@@] 4([H] ) \C([C@H] (C[C@] 34C) OC(C) =O) =C(/CCC=C(C) C) C(O) =O) [C@@] 1(C) CC[C@@H] (O) [C@H] 2C |
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
EC 2.7.1.33 (pantothenate kinase) inhibitor
An EC 2.7.1.* (phosphotransferases with an alcohol group as acceptor) inhibitor that interferes with the action of pantothenate kinase (EC 2.7.1.33).
protein synthesis inhibitor
A compound, usually an anti-bacterial agent or a toxin, which inhibits the synthesis of a protein.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via carbocyclic antibiotic )
|
|
View more via ChEBI Ontology
(2Z)- 2- [(17Z)- 16β- acetoxy- 3α,11α- dihydroxy- 4α,8α,10,14β- tetramethyl- 5α,9β,13α- gonan- 17- ylidene]- 6- methylhept- 5- enoic acid
|
fucidic acid
|
ChEBI
|
Fucidin acid
|
ChemIDplus
|
Fusidic acid
|
KEGG COMPOUND
|
Fusidine
|
ChemIDplus
|
Ramycin
|
ChemIDplus
|
1261
|
DrugCentral
|
1776
|
VSDB
|
C00023903
|
KNApSAcK
|
C06694
|
KEGG COMPOUND
|
CPD0-1606
|
MetaCyc
|
D04281
|
KEGG DRUG
|
DB02703
|
DrugBank
|
FUA
|
PDBeChem
|
Fusidic_acid
|
Wikipedia
|
HMDB0015570
|
HMDB
|
LMPR0106040001
|
LIPID MAPS
|
View more database links |
2197692
|
Reaxys Registry Number
|
Reaxys
|
5672885
|
Beilstein Registry Number
|
Beilstein
|
6990-06-3
|
CAS Registry Number
|
ChemIDplus
|
|